Myocarditis Risk Following mRNA COVID Shots May Be Far Higher Than Previously Estimated
A new study conducted by researchers from the U.S. Centers for Disease Control and Prevention (CDC) and several universities and hospitals in the United States shows that the risk of myocarditis (inflammation of the heart muscle) after receiving a messenger RNA (mRNA) COVID-19 biologic is 133 times greater than the normal risk for the condition in the general population. The researchers, who used data from the CDC’s Vaccine Adverse Event Reporting System (VAERS), noted that, given the passive reporting nature of VAERS, the risk of myocarditis is likely to be even higher.1 2 3 According to the study: